Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The study is to evaluate the antiemetic effect of adding fosaprepitant to biplet regimen of tropisetron and dexamethasone for patients with cervical cancer or nasopharyngeal cancer treated with radiotherapy and concomitant weekly cisplatin chemotherapy in a south Chinese cohort.
Epistemonikos ID: 329848babdf435f063a42d1902b9c4947228e347
First added on: May 13, 2024